Literature DB >> 8741063

Multifocal vascular lesions of bone: imaging characteristics.

L M Lomasney1, S Martinez, T C Demos, J M Harrelson.   

Abstract

OBJECTIVE: Multifocal vascular processes which arise in bone are a very inhomogeneous class of diseases. Four of these processes are derived from endothelial precursors, however, and share a similar radiographic spectrum. These four entities are reviewed in order to clarify their imaging patterns and the diagnostic utility of imaging modalities.
METHODS: Eight cases of cystic angiomatosis, multifocal hemangioma, hemangioendothelioma and angiosarcoma presenting to a tertiary referral center over a 7-year period were reviewed. The medical literature was also reviewed for information concerning the imaging of these processes.
RESULTS: All four diseases produced radiolucent defects on plain radiographs with variable margination reflecting the aggressiveness of the lesions. Computed tomography was used to examine five patients and provided supportive, though generally non-diagnostic, information in the five cases in which it was performed. Radionuclide bone scintigraphy, as reported in the literature, underestimated the extent of skeletal involvement in all eight cases, though some lesions were identified. Radionuclide imaging with labeled red blood cells, performed in three cases, did not add any information, which is contrary to some reports in the literature. Magnetic resonance imaging proved the most sensitive for identifying lesions, although the imaging characteristics were not diagnostic.
CONCLUSIONS: Plain radiographs are the mainstay for imaging multifocal endothelial processes. Radiographs provide information on aggressiveness, multifocality and distribution of lesions. Computed tomography provides similar information. Magnetic resonance imaging often detects additional lesions. The insensitivity of radionuclide bone scintigraphy is surprising. Reports of unique deposition of radionuclide in tagged red blood cell scanning has been reported to support the diagnosis of vascular lesions, but it did not do so in these cases.

Entities:  

Mesh:

Year:  1996        PMID: 8741063     DOI: 10.1007/s002560050075

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  7 in total

1.  Advantages in vascular tumors.

Authors:  Jendrik Hardes; Georg Gosheger
Journal:  Dtsch Arztebl Int       Date:  2010-10-22       Impact factor: 5.594

Review 2.  Angiosarcoma: clinical and imaging features from head to toe.

Authors:  Ayman H Gaballah; Corey T Jensen; Sarah Palmquist; Perry J Pickhardt; Alper Duran; Gregory Broering; Khaled M Elsayes
Journal:  Br J Radiol       Date:  2017-05-04       Impact factor: 3.039

Review 3.  Protracted disseminated skeletal metastases from angiosarcoma of the spleen.

Authors:  B Jobke; M Werner; G Jundt; H Ostertag; J Freyschmidt
Journal:  Clin Exp Metastasis       Date:  2010-02-21       Impact factor: 5.150

4.  Angiosarcoma of the humerus presenting with fluid-fluid levels on MRI: a unique imaging presentation.

Authors:  Brent Griffith; Sumit Yadam; Theodore Mayer; Michael Mott; Marnix van Holsbeeck
Journal:  Skeletal Radiol       Date:  2013-05-31       Impact factor: 2.199

5.  Multicentric Primary Angiosarcoma of Bone Mimicking Metastasis on (18)F-FDG PET/CT in a Patient with a History of Sigmoid Colon Cancer: a Case Report.

Authors:  Min Young Yoo; Eun Seong Lee; Seok-Ki Kim; Seog-Yun Park; Youngmee Kwon; Tak Yun; Tae Sung Kim
Journal:  Nucl Med Mol Imaging       Date:  2015-07-24

Review 6.  Cystic angiomatosis, a heterogeneous condition: Four new cases and a literature review.

Authors:  Aurélie Najm; Elise Soltner-Neel; Benoît Le Goff; Pascale Guillot; Yves Maugars; Jean-Marie Berthelot
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

7.  Primary Angiosarcoma of Humerus - A Case Report and Literature Review.

Authors:  Madhan Jeyaraman; Sathish Muthu; Manoj Prabhakar; Naveen Jeyaraman; Garima Agarwal; Rashmi Jain
Journal:  J Orthop Case Rep       Date:  2021-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.